ARTLVSSXTC• 12 Months (Normalized)
ARTL vs SXTC (Artelo Biosciences Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-96.34%
Artelo Biosciences Inc.
Normalized Baseline0.00%
SXTC Performance $2.51
+%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin SXTC LEADS
-96.34 pts
SXTC outperforming by 96.34 percentage points
ARTLSXTC
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | ARTL Price | ARTL Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -96.34% | $- | - | |
| Sep 24, 2026 | $5.17 | -95.83% | $- | - | |
| Sep 23, 2026 | $7.31 | -94.10% | $2.51 | -99.99% | +5.89% |
| Sep 22, 2026 | $4.15 | -96.65% | $- | - | |
| Sep 21, 2026 | $4.10 | -96.69% | $2.38 | -99.99% | +3.30% |
| Sep 18, 2026 | $3.94 | -96.82% | $2.40 | -99.99% | +3.17% |
| Sep 17, 2026 | $3.97 | -96.80% | $2.44 | -99.99% | +3.19% |
| Sep 16, 2026 | $3.75 | -96.97% | $2.19 | -99.99% | +3.02% |
| Sep 15, 2026 | $5.34 | -95.69% | $2.36 | -99.99% | +4.30% |
| Sep 14, 2026 | $4.87 | -96.07% | $2.66 | -99.99% | +3.92% |
| Sep 11, 2026 | $5.43 | -95.62% | $2.56 | -99.99% | +4.37% |
| Sep 10, 2026 | $5.63 | -95.46% | $1.93 | -99.99% | +4.53% |
| Sep 09, 2026 | $5.98 | -95.17% | $2.14 | -99.99% | +4.82% |
| Sep 08, 2026 | $6.19 | -95.01% | $2.24 | -99.99% | +4.98% |
| Sep 04, 2026 | $6.04 | -95.13% | $2.23 | -99.99% | +4.86% |
Page 1 of 17